NSUN5 promotes progression and predicts poor prognosis in hepatocellular carcinoma

Zhang,Xiao-Wen; Zhang,Xiao-Wen; Zhang,Xiao-Wen; Wu,Lu-Yi; Wu,Lu-Yi; Wu,Lu-Yi; Liu,Hui-Rong; Liu,Hui-Rong; Liu,Hui-Rong; Huang,Yan; Huang,Yan; Huang,Yan; Qi,Qin; Qi,Qin; Qi,Qin; Zhong,Rui; Zhong,Rui; Zhong,Rui; Zhu,Lu; Zhu,Lu; Zhu,Lu; Gao,Chun-Fang; Gao,Chun-Fang; Gao,Chun-Fang; Zhou,Lin; Zhou,Lin; Zhou,Lin; Yu,Jian; Yu,Jian; Yu,Jian; Wu,Huan-Gan; Wu,Huan-Gan; Wu,Huan-Gan

doi:10.3892/ol.2022.13559

NSUN5 promotes progression and predicts poor prognosis in hepatocellular carcinoma

Authors:
- Xiao-Wen Zhang
- Lu-Yi Wu
- Hui-Rong Liu
- Yan Huang
- Qin Qi
- Rui Zhong
- Lu Zhu
- Chun-Fang Gao
- Lin Zhou
- Jian Yu
- Huan-Gan Wu
View Affiliations

Affiliations: Department of Acupuncture and Moxibustion, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, P.R. China, Department of Laboratory Medicine, Changzheng Hospital, Naval Medical University, Shanghai 200003, P.R. China, The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai 200438, P.R. China
Published online on: October 21, 2022 https://doi.org/10.3892/ol.2022.13559
Article Number: 439
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The 5‑methylcytosine (m5C) RNA methyltransferase NOP2/Sun RNA methyltransferase 5 (NSUN5) has been reported to serve important roles in numerous diseases. However, the functions and clinical significance of NSUN5 in hepatocellular carcinoma (HCC) remain unknown. Clinical information and NSUN5 mRNA sequencing data for 374 patients with HCC were downloaded from The Cancer Genome Atlas (TCGA) database, and NSUN5 mRNA and protein expression levels in 120 patients with HCC (present study cohorts) were assessed using reverse transcription‑quantitative PCR, western blotting or immunohistochemistry. The association between NSUN5 mRNA and protein expression levels and the clinical characteristics (or prognosis) of patients with HCC was analyzed using the χ2 or log‑rank test. The functions of NSUN5 in HCC were evaluated using in vitro and in vivo experiments, and the mechanism by which NSUN5 affected the progression of HCC was assessed using bioinformatics analysis using LinkedOmics. NSUN5 was significantly upregulated and predicted poor prognosis in HCC according to data from both TCGA database and present study cohorts. NSUN5 significantly promoted HCC proliferation and migration in vitro and significantly induced HCC tumor growth in vivo. Bioinformatics analysis demonstrated that NSUN5 was positively correlated with genes associated with translation in HCC. It was hypothesized that overexpression of NSUN5 strengthened ribosome functions and global protein translation, which may promote the proliferation and migration of HCC. In conclusion, NSUN5 may promote the progression of HCC by enhancing translation, thus making it a potential target for HCC treatment.

View Figures

View References

1	Cao W, Chen HD, Yu YW, Li N and Chen WQ: Changing profiles of cancer burden worldwide and in China: A secondary analysis of the global cancer statistics 2020. Chin Med J (Engl). 134:783–791. 2021. View Article : Google Scholar : PubMed/NCBI
2	Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J and Finn RS: Hepatocellular carcinoma. Nat Rev Dis Primers. 7:62021. View Article : Google Scholar : PubMed/NCBI
3	Puisieux MF, Pellat A, Assaf A, Ginestet C, Brezault C, Dhooge M, Soyer P and Coriat R: Therapeutic management of advanced hepatocellular carcinoma: An updated review. Cancers (Basel). 14:23572022. View Article : Google Scholar
4	Gao Y and Fang J: RNA 5-methylcytosine modification and its emerging role as an epitranscriptomic mark. RNA Biol. 18:117–127. 2021. View Article : Google Scholar : PubMed/NCBI
5	Cheng JX, Chen L, Li Y, Cloe A, Yue M, Wei J, Watanabe KA, Shammo JM, Anastasi J, Shen QJ, et al: RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia. Nat Commun. 9:1163. 2018. View Article : Google Scholar : PubMed/NCBI
6	Selmi T, Hussain S, Dietmann S, Heiß M, Borland K, Flad S, Carter JM, Dennison R, Huang YL, Kellner S, et al: Sequence- and structure-specific cytosine-5 mRNA methylation by NSUN6. Nucleic Acids Res. 49:1006–1022. 2021. View Article : Google Scholar : PubMed/NCBI
7	Frye M, Harada BT, Behm M and He C: RNA modifications modulate gene expression during development. Science. 361:1346–1349. 2018. View Article : Google Scholar : PubMed/NCBI
8	Janin M, Ortiz-Barahona V, de Moura MC, Martínez-Cardús A, Llinàs-Arias P, Soler M, Nachmani D, Pelletier J, Schumann U, Calleja-Cervantes ME, et al: Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program. Acta Neuropathol. 138:1053–1074. 2019. View Article : Google Scholar : PubMed/NCBI
9	Jiang Z, Li S, Han MJ, Hu GM and Cheng P: High expression of NSUN5 promotes cell proliferation via cell cycle regulation in colorectal cancer. Am J Transl Res. 12:3858–3870. 2020.PubMed/NCBI
10	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
11	Hu L, Lau SH, Tzang CH, Wen JM, Wang W, Xie D, Huang M, Wang Y, Wu MC, Huang JF, et al: Association of Vimentin overexpression and hepatocellular carcinoma metastasis. Oncogene. 23:298–302. 2004. View Article : Google Scholar : PubMed/NCBI
12	Tao QF, Yuan SX, Yang F, Yang Y, Yuan JH, Wang ZG, Xu QG, Lin KY, Cai J, Yu J, et al: Aldolase B inhibits metastasis through Ten-Eleven Translocation 1 and serves as a prognostic biomarker in hepatocellular carcinoma. Mol Cancer. 14:1702015. View Article : Google Scholar : PubMed/NCBI
13	Budwit-Novotny DA, McCarty KS, Cox EB, Soper JT, Mutch DG, Creasman WT, Flowers JL and McCarty KS Jr: Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Res. 46:5419–5425. 1986.PubMed/NCBI
14	Hou G, Chen L, Liu G, Li L, Yang Y, Yan HX, Zhang HL, Tang J, Yang YC, Lin X, et al: Aldehyde dehydrogenase-2 (ALDH2) opposes hepatocellular carcinoma progression by regulating AMP-activated protein kinase signaling in mice. Hepatology. 65:1628–1644. 2017. View Article : Google Scholar : PubMed/NCBI
15	Tandon N, Thakkar KN, LaGory EL, Liu Y and Giaccia AJ: Generation of stable expression mammalian cell lines using lentivirus. BIO Protoc. 8:e30732018. View Article : Google Scholar : PubMed/NCBI
16	Liu F, Yuan JH, Huang JF, Yang F, Wang TT, Ma JZ, Zhang L, Zhou CC, Wang F, Yu J, et al: Long noncoding RNA FTX inhibits hepatocellular carcinoma proliferation and metastasis by binding MCM2 and miR-374a. Oncogene. 35:5422–5434. 2016. View Article : Google Scholar : PubMed/NCBI
17	Workman P, Aboagye EO, Balkwill F, Bruder G, Chaplin DJ, Double JA, Everitt J, Farningham DAH, Glennie MJ, Kelland LR, et al: Guidelines for the welfare and use of animals in cancer research. Br J Cancer. 102:1555–1577. 2010. View Article : Google Scholar : PubMed/NCBI
18	Vasaikar SV, Straub P, Wang J and Zhang B: LinkedOmics: Analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 46:D956–D963. 2018. View Article : Google Scholar : PubMed/NCBI
19	Cancer Genome Atlas Research Network. Electronic address, . simplewheeler@bcm.edu; Cancer Genome Atlas Research Network: Comprehensive and integrative genomic characterization of hepatocellular carcinoma. Cell. 169:1327–1341.e23. 2017. View Article : Google Scholar : PubMed/NCBI
20	Liao X and Zhang D: The 8th edition american joint committee on cancer staging for hepato-pancreato-biliary cancer: A review and update. Arch Pathol Lab Med. 145:543–553. 2021. View Article : Google Scholar : PubMed/NCBI
21	Yu J, Xu QG, Wang ZG, Yang Y, Zhang L, Ma JZ, Sun SH, Yang F and Zhou WP: Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma. J Hepatol. 68:1214–1227. 2018. View Article : Google Scholar : PubMed/NCBI
22	Reig M, Forner A, Rimola J, Ferrer-Fàbrega J, Burrel M, Garcia-Criado A, Kelley RK, Galle PR, Mazzaferro V, Salem R, et al: BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. J Hepatol. 76:681–693. 2022. View Article : Google Scholar : PubMed/NCBI
23	Nelson ME, Lahiri S, Chow JDY, Byrne FL, Hargett SR, Breen DS, Olzomer EM, Wu LE, Cooney GJ, Turner N, et al: Inhibition of hepatic lipogenesis enhances liver tumorigenesis by increasing antioxidant defence and promoting cell survival. Nat Commun. 8:14689. 2017. View Article : Google Scholar : PubMed/NCBI
24	Wilson CL, Mann DA and Borthwick LA: Epigenetic reprogramming in liver fibrosis and cancer. Adv Drug Deliv Rev. 121:124–132. 2017. View Article : Google Scholar : PubMed/NCBI
25	Thomas MB, Morris JS, Chadha R, Iwasaki M, Kaur H, Lin E, Kaseb A, Glover K, Davila M and Abbruzzese J: Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma. J Clin Oncol. 27:843–850. 2009. View Article : Google Scholar : PubMed/NCBI
26	Sun HC, Zhu XD, Huang C, Shen YH and Fan J: Initially unresectable hepatocellular carcinoma treated by combination therapy of tyrosine kinase inhibitor and anti-PD-1 antibody followed by resection. J Clin Oncol. 38:e16690. 2020. View Article : Google Scholar
27	Heissenberger C, Liendl L, Nagelreiter F, Gonskikh Y, Yang G, Stelzer EM, Krammer TL, Micutkova L, Vogt S, Kreil DP, et al: Loss of the ribosomal RNA methyltransferase NSUN5 impairs global protein synthesis and normal growth. Nucleic Acids Res. 47:11807–11825. 2019. View Article : Google Scholar : PubMed/NCBI
28	Chen P, Zhang T, Yuan Z, Shen B and Chen L: Expression of the RNA methyltransferase Nsun5 is essential for developing cerebral cortex. Mol Brain. 12:742019. View Article : Google Scholar : PubMed/NCBI
29	Yuan Z, Chen P, Zhang T, Shen B and Chen L: Agenesis and hypomyelination of corpus callosum in mice lacking Nsun5, an RNA methyltransferase. Cells. 8:5522019. View Article : Google Scholar : PubMed/NCBI
30	Hajiasgharzadeh K, Somi MH, Shanehbandi D, Mokhtarzadeh A and Baradaran B: Small interfering RNA-mediated gene suppression as a therapeutic intervention in hepatocellular carcinoma. J Cell Physiol. 234:3263–3276. 2019. View Article : Google Scholar : PubMed/NCBI